Efficacy and Mechanism of Acupoint Catgut Embedding in the Treatment of Chronic Spontaneous Urticaria: Protocol for a Randomized Double-Blind Placebo-Controlled Trial
JMIR Research Protocols · 2024
DOI: 10.2196/54376 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2024. Verfasst von Jianing Bi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Catgut, Acupuncture Points, Chronic Urticaria, Acupuncture Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Chronic spontaneous urticaria (CSU) is a common chronic inflammatory skin disease that manifests as itching and wheals, seriously affecting quality of life. Clinical observations and previous research trials have shown that acupuncture is safe and effective for the treatment of CSU. However, there are problems, such as a short duration of action and frequent treatment. Compared with traditional acupuncture, acupoint catgut embedding (ACE) has the advantages of a longer effect and higher compliance. Clinical trials are needed to prove its efficacy and mechanism of action.
Objective
This trial aims to provide definitive evidence for the treatment of CSU with ACE and explore the mechanism of ACE.
Methods
This is a randomized, double-blind, placebo-controlled trial. In this trial, 108 participants aged 18-60 years with a diagnosis of CSU and no history of ACE will be randomly assigned to 2 groups (1:1 ratio) using the Statistical Analysis System: treatment (ACE) and control (sham ACE). The participants and efficacy evaluators will be blinded to the grouping. Both the ACE and sham ACE groups will undergo acupuncture, but the sham ACE group will not receive catgut sutures. Treatment will be performed twice weekly for 8 weeks, with a 1-week run-in period and a 16-week follow-up period. Twenty patients will be randomly selected to undergo functional magnetic resonance imaging before and after the treatment period. The primary outcome will be the urticaria activity score over 7 days (UAS7). We will use R (version 4.0.1; R Project for Statistical Computing) to perform ANOVA and independent samples t tests to compare the differences within and between groups before and after treatment by judging the rejection range based on a significance level of .05.
Results
The study protocol has been approved by the Ethics Committee of Guang’anmen Hospital on September 7, 2022, and has been registered on November 30, 2022. Recruitment began on March 1, 2023. A total of 4-6 participants are expected to be recruited each month. The recruitment is planned to be completed on March 1, 2025, and we expect to publish our results by the winter of 2025. As of November 1, 2023, we have enrolled 25 participants with CSU.
Conclusions
This randomized, double-blind, placebo-controlled trial aims to provide definitive evidence for the treatment of CSU with ACE and explore the mechanism of ACE. We hypothesize that wheals and itching will show greater improvement in participants receiving active therapy than in those receiving sham treatment. The limitations of this study include its single-center trial design, small sample size, and short treatment duration, which may have certain impacts on the research results. Trial Registration Chinese Clinical Trial Registry ChiCTR2200066274; https://www.chictr.org.cn/showprojEN.html?proj=179056 International Registered Report Identifier (IRRID) DERR1-10.2196/54376
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing University of Chinese Medicine, Beijing, China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
ORCID-Profile: Jianing Bi, Li Liu, Zhu Fan, Shengyuan Qu, Jiao Yang, Chenchen Xu, Bingnan Cui
Zitieren
APA
Bi, J., Liu, L., Fan, Z., Qu, S., Yang, J., Xu, C., & Cui, B. (2024). Efficacy and Mechanism of Acupoint Catgut Embedding in the Treatment of Chronic Spontaneous Urticaria: Protocol for a Randomized Double-Blind Placebo-Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/54376
Vancouver
Bi J, Liu L, Fan Z, Qu S, Yang J, Xu C, et al. Efficacy and Mechanism of Acupoint Catgut Embedding in the Treatment of Chronic Spontaneous Urticaria: Protocol for a Randomized Double-Blind Placebo-Controlled Trial. JMIR Research Protocols. 2024. doi:10.2196/54376
BibTeX
@article{Bi2024,
author = {Bi, Jianing and Liu, Li and Fan, Zhu and Qu, Shengyuan and Yang, Jiao and Xu, Chenchen and Cui, Bingnan},
title = {Efficacy and Mechanism of Acupoint Catgut Embedding in the Treatment of Chronic Spontaneous Urticaria: Protocol for a Randomized Double-Blind Placebo-Controlled Trial},
journal = {JMIR Research Protocols},
year = {2024},
doi = {10.2196/54376}
}
EUVIMED